Intracellular NO-Generator Based on Enzyme Trigger for Localized Tumor-Cytoplasm Rapid Drug Release and Synergetic Cancer Therapy
Authors:
- 18 December 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (1) , 255-268
Abstract
Nitric oxide (NO) is an important biological messenger implicated in tumor therapy. However, current NO release systems suffer from some disadvantages, such as hydrolysis during blood circulation, poor specificity and robust irradiation for stimuli. Accordingly, we constructed an intracellular enzyme-triggered NO-generator to achieve tumor cytoplasm-specific disruption and localized rapid drug release. Diethylamine NONOate (DEA/NO) was used as a NO donor and conjugated with hyaluronic acid (HA) to form self-assembly micelle (HA-DNB-DEA/NO), and encapsulate chemotherapeutic agent (doxorubicin (DOX)) into its hydrophobic core (DOX@HA-DNB-DEA/NO). After HA receptor mediated internalization into tumor cells, HA shell would undergo digestion into small conjugated pieces by hyaluronidase. Meanwhile, DOX@HA-DNB-DEA/NO also responded to the intratumoral over-expressed glutathion and glutathione S-transferase π, leading to the intracellular NO production and controlled DOX rapid release. In vitro and in vivo results proved the enzyme-dependent and enhanced targeting delivery profile, and demonstrated that NO and DOX could co-locate in specific tumor site, which provided a precondition for exerting their synergistic efficacy. Moreover, expression of p53 protein was upregulated in tumor tissue after treatment, indicating that NO induced cell apoptosis mediated by tumor suppressor gene p53. Overall, this intelligent drug loaded NO-generator might perform as an enhancer to realize better clinical outcomes.Keywords
Funding Information
- Zhengzhou University (51099255)
- National Natural Science Foundation of China (U1704172)
- Henan Province (19zx005, 162102310510)
This publication has 51 references indexed in Scilit:
- Nitric oxide and cancer: a reviewWorld Journal of Surgical Oncology, 2013
- Polysaccharide-Based Micelles for Drug DeliveryPharmaceutics, 2013
- Nitric oxide release: Part II. Therapeutic applicationsChemical Society Reviews, 2012
- The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancersCell Research, 2011
- Growth‐inhibitory and chemosensitizing effects of the glutathione‐S‐transferase‐π‐activated nitric oxide donor PABA/NO in malignant gliomasInternational Journal of Cancer, 2011
- Self-assembled hyaluronic acid nanoparticles for active tumor targetingBiomaterials, 2010
- Post-translational modifications induced by nitric oxide (NO): Implication in cancer cells apoptosisNitric Oxide, 2008
- Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan ReceptorMolecular Pharmaceutics, 2008
- Recent developments in nitric oxide donor drugsBritish Journal of Pharmacology, 2007
- Hyaluronan: from extracellular glue to pericellular cueNature Reviews Cancer, 2004